NASDAQ 2019年3月 IPOまとめ(最終版)

この記事は約12分で読めます。
スポンサーリンク

こんにちはぐだおです。
ここでは2019年3月にNASDAQにIPO(新規上場)した企業の情報についてまとめています。このウェブサイトの趣旨から、ここでは調達額が$100,000,000(1億ドル)を超えるものだけを抽出しています。あとブランクチェックカンパニーも載せないことにしました(ブランクチュックカンパニーについてはここに書きました)。ここのページの情報は基本的にはYahoo JAPANのfinanceの情報を参考に加筆・修正したものになります(日本語の会社名にはYahoo JAPANのファイナンスへのリンクが、英語名のほうにはYahoo financeへのリンクが貼ってあります。情報量は英語の方が多いので、もう少し情報が欲しいという方はリンクから飛んでください。)。
今月は巨大企業のIPOがありましたね。

リフト
LYFT, INC
(ティッカーシンボル:LYFT)

市場NASDAQ Global Select
株価$72
株数32,500,000
調達額$2,340,000,000
上場日3/22/2019
本社San Francisco, California
設立年2012
部門Technology
業界Software—Application
従業員数5,380

リフトは米国の配車サービス企業。米国とカナダにおいて、オンラインで配車(ライドシェアリング)サービスを展開する。さまざまな乗車プランから、顧客とドライバーをアプリを通じてマッチングさせ、請求、支払い、サポート、評価などをアプリ上で行うシステム。同社はまた、都市部におけるバイクシェアリングサービスも手掛ける。本社所在地はカリフォルニア州サンフランシスコ。
Lyft, Inc. operates a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. The company offers a multimodal platform that provides riders, personalized and on-demand access to various transportation options. It provides Ridesharing Marketplace, which facilitates lead generation, billing and settlement, support, and related activities to enable drivers to provide their transportation services to riders. The company also offers a network of shared bikes and scooters in various cities to address the needs of riders for shorter routes; Express Drive program, a flexible car rentals program that connects drivers who need access to a car with third-party rental car companies; and concierge for organizations to manage the transportation needs of their customers and employees. In addition, it integrates third-party public transit data into the Lyft app to offer riders various transportation options; offers various enterprise programs, including monthly ride credits for daily commutes, supplementing public transit by providing rides for the first and last leg of commute trips, late-night rides home, and shuttle replacement rides; and provides transportation solutions that can be customized for events, such as recruiting events, conferences, celebrations, meetings, and company retreats. The company was formerly known as Zimride, Inc. and changed its name to Lyft, Inc. in April 2013. Lyft, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

プレシジョン・バイオサイエンシーズ
PRECISION BIOSCIENCES INC
(ティッカーシンボル:DTIL)

市場NASDAQ Global Select
株価$16
株数7,900,000
調達額$126,400,000
上場日3/21/2019
本社Durham, North Carolina
設立年2006
部門Healthcare
業界Biotechnology
従業員数184

プレシジョン・バイオサイエンシーズは、米国のバイオテクノロジー企業。遺伝病の治療、がんの克服および地球規模の食糧問題の解決を目指す。同社独自のゲノム編集プラットフォームARCUSを用い、複雑なゲノムの任意の位置にDNAを挿入、除去、及び修飾するヌクレアーゼ(核酸分解酵素)を製造する。本社所在地はノースカロライナ州ダーラム。
Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products in the United States. It operates through two segments, Therapeutic and Food. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene correction activities. This segment develops PBCAR0191, is an allogeneic CAR T cell therapy targeting the tumor target CD19 for acute lymphoblastic leukemia and non-hodgkin lymphoma; and CD20, BCMA, and CLL-1, CAR T cell therapies targeting the tumor antigens. The Food segment develops food and nutrition products; and pre-breeding materials, a gene edited crop intermediate that could be integrated into breeding program and use in producing new crop varieties. The company has development and commercial license agreement with Shire Plc for research and development of individual T cell modifications; collaboration agreement with Gilead Sciences, Inc. to co-develop a product candidate to cure chronic Hepatitis B infection. Precision BioSciences, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

GENFIT SA
GENFIT SA
(ティッカーシンボル:GNFT)

市場NASDAQ Global Select
株価$20.32
株数6,150,000
調達額$124,968,000
上場日3/27/2019
本社Loos, France
設立年1999
部門Healthcare
業界Biotechnology
従業員数180/td>

Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, and autoimmune or fibrotic diseases affecting primarily the liver and gastro-enterology. The company’s lead products include Elafibranor, which is in pivotal Phase 3 clinical trials for the treatment of nonalcoholic steatohepatitis (NASH), as well as in Phase 2 study in patients with primary biliary cholangitis; and Nitazoxanide that is in Phase 2 proof-of-concept clinical trial for the treatment of NASH-induced significant or severe fibrosis. It is also developing in-vitro diagnostic test for the identification of patients with NASH; and TGFTX1 preclinical program for treating psoriasis or respiratory conditions, such as neutrophilic asthma, chronic obstructive pulmonary disease (COPD), and the asthma-COPD overlap syndrome. Genfit SA was founded in 1999 and is headquartered in Loos, France.

リーバイ・ストラウス
LEVI STRAUSS & CO
(ティッカーシンボル:LEVI)

市場NYSE
株価$17
株数36,666,667
調達額$623,333,339
上場日3/21/2019
本社San Francisco, California
設立年1853
部門Consumer Cyclical
業界Apparel Manufacturing
従業員数15,100

リーバイ・ストラウスは米国のアパレル企業。通称はリーバイスで、主にジーンズやデニム製品を製造・販売する。同社ブランド名Levi’s、Dockers、Denizenなどでジーンズ、ドレスパンツ、ショートパンツ、ジャケットなどを自社製造、第三者製造およびライセンス契約で事業を展開する。アジア、欧州、北米および南米が主要市場。本社所在地はサンフランシスコ。
Levi Strauss & Co. designs, markets, and sells jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear, and related accessories for men, women, and children. The company sells its products under the Levi’s, Dockers, Signature by Levi Strauss & Co., and Denizen brands; and also licenses its Levi’s and Dockers trademarks for various product categories, including footwear, belts, wallets and bags, outerwear, sweaters, dress shirts, kids wear, sleepwear, and hosiery. Levi Strauss & Co. sells its products in approximately 110 countries through a network of chain retailers, department stores, specialty retailers, franchised or other brand-dedicated stores, and shop-in-shops, as well as e-commerce sites. The company operates approximately 3,000 retail stores and shop-in-shops. Levi Strauss & Co. was founded in 1853 and is headquartered in San Francisco, California.

タイガーロジックス
UP FINTECH HOLDING LTD
(ティッカーシンボル:TIGR)

市場NASDAQ Global Select
株価$8
株数13,000,000
調達額$104,000,000
上場日3/20/2019
本社
設立年2014
部門Financial Services
業界Capital Markets
従業員数575

タイガーロジックスは、アプリケーション開発ソフトウェアの米国メーカー。迅速なアプリケーション開発ソフトウェアとソーシャル・モバイル・プラットフォーム(ソーシャル・メディア・コンテンツの集約と可視化プラットフォーム、インターネット検索向上ツール、モバイル・アプリケーション)の設計・開発・販売・サポートに従事する。
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform that can be accessed through its APP and website. It offers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support. The company was founded in 2014 and is based in Beijing, China.

コメント

タイトルとURLをコピーしました